NCT02059668 - Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio) | Biotech Hunter

Enrollment

588

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL

Biomarker analyses head & neck cancer tissue, blood specimen

For biomarker analyses, tumor tissues from previous biopsies and surgery and blood specimens taken during treatment at the treating institution will be used.

Trial Locations (10)

10117

Prof. Volker Budach, Berlin

45147

Prof. Martin Stuschke, Essen

60590

Prof. Claus Rödel, Frankfurt am Main

69120

Prof. Jürgen Debus, Heidelberg

72016

Prof. Daniel Zips, Tübingen

79106

Prof. Anca-Ligia Grosu, Freiburg im Breisgau

81377

Prof. Claus Belka, München

81675

Prof. Stephanie Combs, München

01307

Prof. Mechthild Krause, Dresden

01067

Praxis für Strahlentherapie im Krankenhaus Dresden - Friedrichstadt, Dresden

All Listed Sponsors

lead

Technische Universität Dresden

OTHER